229 related articles for article (PubMed ID: 17721088)
1. Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates.
Low AJ; Dong W; Chan D; Sing T; Swanstrom R; Jensen M; Pillai S; Good B; Harrigan PR
AIDS; 2007 Sep; 21(14):F17-24. PubMed ID: 17721088
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two genotypic algorithms to determine HIV-1 tropism.
Soulié C; Derache A; Aimé C; Marcelin AG; Carcelain G; Simon A; Katlama C; Calvez V
HIV Med; 2008 Jan; 9(1):1-5. PubMed ID: 18199166
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
[TBL] [Abstract][Full Text] [Related]
4. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.
Poveda E; Seclén E; González Mdel M; García F; Chueca N; Aguilera A; Rodríguez JJ; González-Lahoz J; Soriano V
J Antimicrob Chemother; 2009 May; 63(5):1006-10. PubMed ID: 19261623
[TBL] [Abstract][Full Text] [Related]
5. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates.
Sing T; Low AJ; Beerenwinkel N; Sander O; Cheung PK; Domingues FS; Büch J; Däumer M; Kaiser R; Lengauer T; Harrigan PR
Antivir Ther; 2007; 12(7):1097-106. PubMed ID: 18018768
[TBL] [Abstract][Full Text] [Related]
6. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.
Raymond S; Delobel P; Mavigner M; Cazabat M; Souyris C; Sandres-Sauné K; Cuzin L; Marchou B; Massip P; Izopet J
AIDS; 2008 Sep; 22(14):F11-6. PubMed ID: 18753930
[TBL] [Abstract][Full Text] [Related]
7. Co-receptor switch during HAART is independent of virological success.
Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
[TBL] [Abstract][Full Text] [Related]
8. Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools.
Chueca N; Garrido C; Alvarez M; Poveda E; de Dios Luna J; Zahonero N; Hernández-Quero J; Soriano V; Maroto C; de Mendoza C; García F
J Med Virol; 2009 May; 81(5):763-7. PubMed ID: 19319937
[TBL] [Abstract][Full Text] [Related]
9. Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals.
Brumme ZL; Goodrich J; Mayer HB; Brumme CJ; Henrick BM; Wynhoven B; Asselin JJ; Cheung PK; Hogg RS; Montaner JS; Harrigan PR
J Infect Dis; 2005 Aug; 192(3):466-74. PubMed ID: 15995960
[TBL] [Abstract][Full Text] [Related]
10. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
11. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
12. HIV coreceptor phenotyping in the clinical setting.
Low AJ; Swenson LC; Harrigan PR
AIDS Rev; 2008; 10(3):143-51. PubMed ID: 18820716
[TBL] [Abstract][Full Text] [Related]
13. CD4-dependent characteristics of coreceptor use and HIV type 1 V3 sequence in a large population of therapy-naive individuals.
Low AJ; Marchant D; Brumme CJ; Brumme ZL; Dong W; Sing T; Hogg RS; Montaner JS; Gill V; Cheung PK; Harrigan PR
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):219-28. PubMed ID: 18240966
[TBL] [Abstract][Full Text] [Related]
14. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of genotypic tropism prediction tests compared with in vitro co-receptor usage in HIV-1 primary isolates of diverse subtypes.
Delgado E; Fernández-García A; Vega Y; Cuevas T; Pinilla M; García V; Sánchez M; González M; Sánchez AM; Thomson MM; Pérez-Álvarez L
J Antimicrob Chemother; 2012 Jan; 67(1):25-31. PubMed ID: 22010208
[TBL] [Abstract][Full Text] [Related]
16. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples.
Saracino A; Monno L; Punzi G; Cibelli DC; Tartaglia A; Scudeller L; Brindicci G; Lagioia A; Scotto G; Angarano G
Virus Res; 2007 Dec; 130(1-2):34-42. PubMed ID: 17582634
[TBL] [Abstract][Full Text] [Related]
18. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays.
Van Baelen K; Vandenbroucke I; Rondelez E; Van Eygen V; Vermeiren H; Stuyver LJ
J Virol Methods; 2007 Dec; 146(1-2):61-73. PubMed ID: 17640743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]